Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

The study will assess the efficacy and safety of SPARC1310 when compared to placebo and active control

Inclusion Criteria:

• Male or female participants aged 18 to 65 years with history of seasonal allergic rhinitis
• Participants able to understand and willing to sign the informed consent form

Exclusion Criteria:

• Anotomical deviations of the nasal septum that significantly impair ventilation or airflow
• Pregnant or nursing women
• Positive serology for infectious disease (Hepatitis B or C, HIV) at screening
• Parallel participation in another current investigational study, participation in a study within less than 30 days prior to study entry, or previous participation in this same study.